4.5 Article

Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension

期刊

HYPERTENSION RESEARCH
卷 35, 期 7, 页码 750-755

出版社

SPRINGERNATURE
DOI: 10.1038/hr.2012.19

关键词

ambulatory blood pressure monitoring; home blood pressure monitoring; masked hypertension; white coat hypertension

向作者/读者索取更多资源

Several studies with relatively small size and different design and end points have investigated the diagnostic ability of home blood pressure (HBP). This study investigated the usefulness of HBP compared with ambulatory monitoring (ABP) in diagnosing sustained hypertension, white coat phenomenon (WCP) and masked hypertension (MH) in a large sample of untreated and treated subjects using a blood pressure (BP) measurement protocol according to the current guidelines. A total of 613 subjects attending a hypertension clinic (mean age 53 +/- 12.4 (s.d.) years, men 57%, untreated 59%) had measurements of clinic BP (three visits, triplicate measurements per visit), HBP (6 days, duplicate morning and evening measurements) and awake ABP (20-min intervals) within 6 weeks. Sustained hypertension was diagnosed in 50% of the participants by ABP and HBP (agreement 89%, kappa=0.79), WCP in 14 and 15%, respectively (agreement 89%, kappa=0.56) and MH in 16% and 15% (agreement 88%, kappa=0.52). Only 4% of the subjects (27/613) showed clinically significant diagnostic disagreement with BP deviation > 5 mm Hg above the diagnostic threshold (for HBP or ABP). By taking ABP as reference, the sensitivity, specificity, positive and negative predictive value of HBP in detecting sustained hypertension were 90, 89, 89 and 90%, respectively, WCP 61, 94, 64 and 94% and MH 60, 93, 60 and 93%. Similar diagnostic agreement was found in untreated and treated subjects. HBP appears to be a reliable alternative to ABP in the diagnosis of hypertension and the detection of WCP and MH in both untreated and treated subjects. Hypertension Research (2012) 35, 750-755; doi:10.1038/hr.2012.19; published online 23 February 2012

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

Validation of the InBody BPBIO210 manual auscultatory hybrid device for professional office use in a general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard

Angeliki Ntineri, Ariadni Menti, Konstantinos G. Kyriakoulis, Ioanna Bountzona, Sofia Prapa, Anastasios Kollias, George S. Stergiou

Summary: This study evaluated the accuracy of the InBody BPBIO210 manual auscultatory hybrid blood pressure measuring device in a general population and demonstrated its compliance with the AAMI/ESH/ISO Universal Standard, making it suitable for clinical use.

BLOOD PRESSURE MONITORING (2022)

Editorial Material Cardiac & Cardiovascular Systems

Evidence on the clinical relevance of short-term blood pressure variability? Untying the Gordian knot

Anastasios Kollias, Konstantinos G. Kyriakoulis, George S. Stergiou

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Review Engineering, Biomedical

Cuffless Blood Pressure Measurement

Ramakrishna Mukkamala, George S. Stergiou, Alberto P. Avolio

Summary: Cuffless blood pressure measurement is a popular research field driven by clinical need and technological opportunity. This review provides an overview of the development and application of cuffless BP measurement methods, including the principles of conventional BP measurement, the problems that cuffless methods can address, the technological advances that are driving the field, and the current evidence of various cuffless methods under investigation.

ANNUAL REVIEW OF BIOMEDICAL ENGINEERING (2022)

Article Peripheral Vascular Disease

Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension

Thomas Weber, Jaques Amar, Tine de Backer, Thilo Burkard, Marcus van der Giet, Philippe Gosse, Andrzej Januszewicz, Thomas Kahan, Giuseppe Mancia, Christopher C. Mayer, Maria Lorenza Muiesan, George S. Stergiou, Konstantinos Tsioufis, Bernard Vaisse, Reinhold Kreutz

Summary: The Covid-19 pandemic led to a significant decrease in non-Covid-19 related hypertension care procedures. The first wave and lockdown period saw the largest reduction in diagnostic and therapeutic procedures related to hypertension. The long-term consequences on blood pressure control and cardiovascular events need further investigation.

BLOOD PRESSURE (2022)

Correction Cardiac & Cardiovascular Systems

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Mar, 10.1007/s00392-022-01996-2, 2022)

Gregory Y. H. Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Chang-Sheng Ma, Kenneth J. Rothman, Sabrina Marler, Venkatesh Kumar Gurusamy, Menno V. Huisman

Summary: The name of the GLORIA-AF investigator was mistakenly written as Athanasios Kollias instead of Anastasios Kollias in the Acknowledgements section of the article. The error has been corrected.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Gregory Y. H. Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Chang-Sheng Ma, Kenneth J. Rothman, Sabrina Marler, Venkatesh Kumar Gurusamy, Menno Huisman

Summary: This study compared the safety and effectiveness of different non-vitamin K antagonists (NOACs) in newly diagnosed atrial fibrillation (AF) patients. The results showed that dabigatran had a lower risk of major bleeding compared to rivaroxaban, but similar risks of stroke, myocardial infarction (MI), and death. Patients treated with dabigatran had similar risks of stroke, major bleeding, MI, and death compared to apixaban. Rivaroxaban had an increased risk of major bleeding compared to apixaban, but similar risks of stroke, MI, and death.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Review Peripheral Vascular Disease

Automated 'oscillometric' blood pressure measuring devices: how they work and what they measure

James E. Sharman, Isabella Tan, George S. Stergiou, Carolina Lombardi, Francesca Saladini, Mark Butlin, Raj Padwal, Kei Asayama, Alberto Avolio, Tammy M. Brady, Alan Murray, Gianfranco Parati

Summary: Automated oscillometric blood pressure measuring devices have replaced manual auscultatory blood pressure measurement by mercury sphygmomanometers in clinical settings. These validated devices provide similar blood pressure values to manual measurement, making them the recommended standard for hypertension diagnosis and management globally.

JOURNAL OF HUMAN HYPERTENSION (2023)

Article Peripheral Vascular Disease

Implementation of the 2018 ESC/ESH Guidelines for the management of hypertension in primary care: the HYPEDIA study

Anastasios Kollias, Emmanouil Foukarakis, Konstantinos Karakousis, George S. Stergiou

Summary: The HYPEDIA study evaluated the implementation of the 2018 European guidelines for treating hypertension in primary care. The study found that renin-angiotensin system blocker-based therapy is widely used in primary care, and single-pill combination drugs are commonly prescribed. However, treatment was not intensified in almost half of the uncontrolled hypertensive patients, suggesting suboptimal implementation of the guidelines.

JOURNAL OF HUMAN HYPERTENSION (2023)

Review Peripheral Vascular Disease

How to find and use validated blood pressure measuring devices

Dean S. Picone, Raj Padwal, George S. Stergiou, Jordana B. Cohen, Richard J. McManus, Siegfried Eckert, Kei Asayama, Neil Atkins, Michael Rakotz, Cintia Lombardi, Tammy M. Brady, James E. Sharman

Summary: Clinically validated, automated arm-cuff blood pressure measuring devices are recommended for accurate measurement. However, most devices available for consumers lack proper validation, which increases the risk of misdiagnosis and mismanagement of blood pressure. Validated device lists have been developed to address this issue, but there are still challenges to overcome.

JOURNAL OF HUMAN HYPERTENSION (2023)

Review Cardiac & Cardiovascular Systems

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension

Aletta E. Schutte, Tazeen H. Jafar, Neil R. Poulter, Albertino Damasceno, Nadia A. Khan, Peter M. Nilsson, Jafar Alsaid, Dinesh Neupane, Kazuomi Kario, Hind Beheiry, Sofie Brouwers, Dylan Burger, Fadi J. Charchar, Myeong Chan Cho, Tomasz J. Guzik, Ghazi F. Haji Al-Saedi, Muhammad Ishaq, Hiroshi Itoh, Erika S. W. Jones, Taskeen Khan, Yoshihiro Kokubo, Praew Kotruchin, Elizabeth Muxfeldt, Augustine Odili, Mansi Patil, Udaya Ralapanawa, Cesar A. Romero, Markus P. Schlaich, Abdulla Shehab, Ching Siew Mooi, U. Muscha Steckelings, George Stergiou, Rhian M. Touyz, Thomas Unger, Richard D. Wainford, Ji-Guang Wang, Bryan Williams, Brandi M. Wynne, Maciej Tomaszewski

Summary: Hypertension is the leading cause of preventable death globally, but there are significant challenges in its detection, treatment, and control, particularly in low-resource settings. Disparities based on resources, sociodemographic environment, and race contribute to the disproportionate burden of hypertension-related outcomes. Immediate action is needed to address these challenges and reduce inequities in hypertension care.

CARDIOVASCULAR RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study

George S. Stergiou, Angeliki Ntineri, Ariadni Menti, Natasa Kalpourtzi, Charalambos Vlachopoulos, Evangelos N. Liberopoulos, Loukianos Rallidis, Dimitris Richter, Magda Gavana, Apostolos Vantarakis, Grigoris Chlouverakis, Christos Hajichristodoulou, Grigoris Trypsianis, Paraskevi V. Voulgari, Yannis Alamanos, Argiro Karakosta, Giota Touloumi

Summary: A nationwide survey conducted in Greece revealed that hypercholesterolemia is responsible for 27% of cardiovascular deaths. The study found that the Greek population generally has high cholesterol levels, with a significant proportion requiring lipid-lowering drugs.

HELLENIC JOURNAL OF CARDIOLOGY (2023)

Review Peripheral Vascular Disease

The Microsoft Research Aurora Project: Important Findings on Cuffless Blood Pressure Measurement

Ramakrishna Mukkamala, Sanjeev G. Shroff, Cederick Landry, Konstantinos G. Kyriakoulis, Alberto P. Avolio, George S. Stergiou

Summary: Conventional blood pressure measurement devices only provide a limited view of continuous blood pressure profile. Wearable cuffless blood pressure devices utilizing pulse wave analysis and pulse arrival time have the potential to significantly improve the assessment and management of hypertension. The Aurora Project, conducted by Microsoft Research, evaluated the accuracy of various cuffless blood pressure devices and found negative results. This article discusses the emerging technologies, summarizes the Aurora Project, and highlights its implications, study methodology, and limitations.

HYPERTENSION (2023)

Review Peripheral Vascular Disease

Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension-2021 NHLBI Workshop Report

Michelle L. Gumz, Daichi Shimbo, Marwah Abdalla, Ravi C. Balijepalli, Christian Benedict, Yabing Chen, David J. Earnest, Karen L. Gamble, Scott R. Garrison, Ming C. Gong, John B. Hogenesch, Yuling Hong, Jessica R. Ivy, Bina Joe, Aaron D. Laposky, Mingyu Liang, Eric J. MacLaughlin, Tami A. Martino, David M. Pollock, Susan Redline, Amy Rogers, R. Dan Rudic, Eva S. Schernhammer, George S. Stergiou, Marie-Pierre St-Onge, Xiaoling Wang, Jacqueline Wright, Young S. Oh

Summary: Healthy individuals experience variation in blood pressure over a 24-hour period, with higher levels during wakefulness and lower levels during sleep. Disruption of the blood pressure circadian rhythm has been associated with negative health outcomes such as cardiovascular disease, dementia, and chronic kidney disease. Current approaches to diagnosis and treatment do not adequately consider the circadian rhythmicity of blood pressure. This review summarizes findings from a workshop held by the National Heart, Lung, and Blood Institute to identify knowledge gaps and research opportunities related to the study of blood pressure circadian rhythm and chronotherapy for hypertension.

HYPERTENSION (2023)

Review Peripheral Vascular Disease

Pathophysiology of the Nondipping Blood Pressure Pattern

Justine Huart, Alexandre Persu, Jean-Philippe Lengele, Jean-Marie Krzesinski, Francois Jouret, George S. Stergiou

Summary: The nondipping blood pressure pattern refers to an inadequate decrease in BP levels during nighttime sleep, disrupting the circadian BP rhythm as observed in 24-hour ambulatory BP monitoring. Patients with this pattern experience poorer renal and cardiovascular outcomes regardless of their average 24-hour BP levels. The pathophysiology of nondipping BP involves disruptions in circadian rhythm, autonomic nervous system, and water and sodium regulation, and recent research has also suggested a potential role of gut microbiota in this pattern.

HYPERTENSION (2023)

Review Peripheral Vascular Disease

The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league

James E. Sharman, Pedro Ordunez, Tammy Brady, Gianfranco Parati, George Stergiou, Paul K. Whelton, Raj Padwal, Michael Hecht Olsen, Christian Delles, Aletta E. Schutte, Maciej Tomaszewski, Daniel T. Lackland, Nadia Khan, Richard J. McManus, Ross T. Tsuyuki, Xin-Hua Zhang, Lisa D. Murphy, Andrew E. Moran, Markus P. Schlaich, Norm R. C. Campbell

JOURNAL OF HUMAN HYPERTENSION (2023)

暂无数据